Bortezomib 2mg Injection

Bortezomib 2mg Injection Specification

Dosage Form
Injection

Salt Composition
Bortezomib 2mg

Indication
Treatment of multiple myeloma and mantle cell lymphoma

Enzyme Types
Proteasome inhibitor

Feature
Sterile, single-use vial

Ingredients
Bortezomib, Mannitol (as stabilizer)

Application
Other

Ph Level
As per company norms

Physical Color/Texture
Lyophilized powder or cake, white to off-white

Fermentation Smell
Normal Smell

Enzymatic Activity
Proteasome inhibition

Storage Instructions
Dry place

Shelf Life
upto 24 Months

Reconstitution
For IV or SC use after reconstitution

Regulatory Status
Rx, Prescription Only Medicine

Solubility
Reconstitute with sterile normal saline (0.9% NaCl)

Packing Type
Vial in carton box

Route of Administration
Intravenous or Subcutaneous injection

Prescription Required
Yes

Bortezomib 2mg Injection Trade Information

Minimum Order Quantity
100 Units

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Units Per Month

Delivery Time
7-10 Seconds

Main Export Market(s)
Asia, Australia, North America, Eastern Europe, Western Europe

Main Domestic Market
All India

About Bortezomib 2mg Injection

Bortezomib 2mg Injection offers an elite level of care in the treatment of multiple myeloma and mantle cell lymphoma. This top-tier, prescription-only medicine is presented in a superb, sterile single-use vial, reconstituted easily with sterile normal saline for intravenous or subcutaneous administration. Its unrivaled efficacy as a proteasome inhibitor is trusted by professionals globally. Packaged securely in a carton box, this product is a popular and bargain choice for exporters and wholesalers, ensuring up to 24 months of shelf life under proper storage conditions.

Special Features & Specific Usage of Bortezomib 2mg Injection

Bortezomib 2mg Injection comes as a sterile, single-use lyophilized powder with a normal smell and white to off-white texture. It is used as an unrivaled proteasome inhibitor, pivotal in treating both multiple myeloma and mantle cell lymphoma. Simply reconstitute with sterile 0.9% NaCl for intravenous or subcutaneous injection. The formulation ensures enhanced stability, making it the preferred choice for those seeking elite, top-tier therapeutic support.

Supply Ability, Payment Terms & Certifications: Exchange for Estimable Value

As a leading exporter and wholesaler from India, we assure a steady supply of Bortezomib 2mg Injection, available at the lowest price estimates in the market. Transactions are streamlined through popular payment options for convenience and security. Each batch is certified to meet regulatory standards, ensuring reliability in exchange for your valued business. With consistent availability, we facilitate prompt delivery for healthcare providers globally.

FAQ's of Bortezomib 2mg Injection:

Q: How is Bortezomib 2mg Injection administered?

A: Bortezomib 2mg Injection is administered either intravenously or subcutaneously after reconstitution with sterile normal saline (0.9% NaCl) as per your doctor's prescription.

Q: What specific conditions is Bortezomib 2mg Injection used to treat?

A: This injection is primarily indicated for the treatment of multiple myeloma and mantle cell lymphoma, providing unrivaled efficacy as a proteasome inhibitor.

Q: When should Bortezomib 2mg Injection be reconstituted for use?

A: Bortezomib 2mg Injection should be reconstituted directly prior to administration, under sterile conditions as instructed by healthcare professionals.